| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |